On Wednesday, January 8, 2023, PharmaCyte Biotech’s CEO, Joshua Silverman, purchased 100,000 shares of PMCB at $0.80 each, totaling $80,476. Following the purchase, the stock peaked at $0.96 during the trading session, reflecting a 19.2% gain at its highest point. The stock was up 10.1% later that day.
In a separate transaction on the same day, Cosmos Health CEO Grigorios Siokas bought 124,880 shares at $0.52 each, amounting to $65,000. Over the past year, Siokas has made 28 purchases of COSM, totaling $1.81 million at an average price of $0.48 per share. On January 8, Cosmos Health’s stock was down about 1% during trading.
